Comparative Study Between Biodentine and Mineral Trioxide Aggregate in Direct Pulp Capping

A Comparative Study of the Performance of Biodentine and Mineral Trioxide Aggregate (MTA) in Direct Pulp Capping of Deeply Carious Teeth.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02803528

Enrollment

Registered

2016-06-17

Start date

2015-01-31

Completion date

2017-10-20

Last updated

2018-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With Deep Carious Lesions

Brief summary

Comparative study between Biodentine and MTA in direct pulp capping of deeply carious teeth.

Interventions

DRUGBiodentine

Biodentine is going to be used as the direct pulp capping material

DRUGMTA

MTA is going to be used as the direct pulp capping material in the second group

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

15 Years to 30 Years

Healthy volunteers

Inclusion criteria

1. asymptomatic vital molars (upper or lower) 2. with complete formation of roots 3. Aged 15 to 30 years. 4. Accidental point pulp exposure during the process of removing dental caries.

Exclusion criteria

1. If the molar not vital. 2. If the molar is symptomatic. 3. Immature molar. 4. Patient not in age between (15-30 years).

Design outcomes

Primary

Measure	Time frame	Description
Success at 3 months following capping	the success of treatment is assessed at three months following the application of the material	Case is considered successful if clinical and radiographic examinations of tooth are sound 100%.
Success at 6 months following capping	the success of treatment is assessed at six months following the application of the material	Case is considered successful if clinical and radiographic examinations of tooth are sound 100%.
Success at 9 months following capping	the success of treatment is assessed at 9 months following the application of the material	Case is considered successful if clinical and radiographic examinations of tooth are sound 100%.
Success at 12 months following capping	the success of treatment is assessed at 12 months following the application of the material	Case is considered successful if clinical and radiographic examinations of tooth are sound 100%.
Success at 18 months following capping	the success of treatment is assessed at 18 months following the application of the material	Case is considered successful if clinical and radiographic examinations of tooth are sound 100%.
Success at 24 months following capping	the success of treatment is assessed at 24 months following the application of the material	Case is considered successful if clinical and radiographic examinations of tooth are sound 100%.

Countries

Syria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026